Tag Archives: biomedical

Bloomington- Who Knew?

Bloomington, Indiana, has one of the most significant clusters of medical-device and life-science companies in the nation. Bloomington is home to industry giants such as Cook Medical, the world’s largest privately held medical device maker, which specializes in minimally invasive surgical devices that allow doctors to operate on patients who are too high-risk for major surgery. Also in Bloomington is the startup Morris Innovative, which has designed an FDA-approved medical device that uses a futuristic new bio-tissue (created by Cook Biotech) to help patients heal faster. Other examples of innovation abound: Indiana University pediatric surgeon Mark Rodefeld has invented a tiny pump that keeps a newborn’s blood oxygenated while surgeons repair the heart of a child born with a single ventricle. Aeon Imaging has developed a laser-scanning digital camera...

Is It Better to be On Your Own or in a Conglomerate?

I came across an interesting short blurb written by Maria Fontonazza entitled “How to Succeed in an Emerging Market” in which she lists what types of markets a medical device company needs in order to be successful.  She lists things we have talked about many times on our blog:
  •  A trained workforce.
  • Engineering skill that is supported by strong universities.
  • Access to risk capital.
  • A strong clinical and physician network.
What I found especially interesting was the fact that that she mentioned one of the challenges to gaining ground in some emerging markets is the cultural stigma around failing. She quotes Glen Giovannetti, Ernst & Young's global life sciences center leader (Boston) who says, “It impedes entrepreneurship because it takes a bold person to leave an academic or corporate job at a successful company and take...

You Smeared What on Your Smartphone?

Hyun Gyu Park and Byoung Yeon Won at the Korea Advanced Institute for Science and Technology in Daejeon, South Korea believe that a biosample – sputum, saliva, blood, or even urine – could be applied to the screen of a smartphone for analysis. They point out that the screen is capable of detecting extraordinarily small differences in capacitance and it’s that capability which can be leveraged to diagnose everything from influenza to salmonella. The value of the analysis though, hinges on the ability to correlate differences in the capacitance of the sample with something clinically relevant.  While current touchscreens are still not able to identify individual pathogens, the touchscreen’s ability to differentiate between concentrations is a crucial first step. I’m not sure if I like this idea or not. ...

New Tenant at Purdue Research Park Offers Drug Delivery System

A company that specializes in developing devices to deliver injected freeze-dried drugs, diagnostics and vaccines has become a tenant in the Purdue Research Park. LyoGo, founded in 2009 by Rush Bartlett, Arthur Chlebowski, and Peter Greco, has developed patent-pending technology that stores a lyophilized, or freeze-dried, drug in one chamber and liquid diluents in the other. David Giddings, a medical industry veteran with more than 30 years of experience, is CEO. Charles Haywood, business development adviser, also is president and CEO of Mansfield-King, a contract manufacturer of personal-care products that was the fifth-fastest growing company in Indiana in 2010. LyoGo was formed for the purpose of developing innovative drug-delivery systems. LyoGo is focused on engineering delivery systems which offer a superior user experience, are intuitive to use, improve safety and sterility, and...